Stanley Center for Psychiatric Research at Broad Institute
| Established | 2007 |
|---|---|
| Research type | Basic (non-clinical) and translational research |
|
Field of research
|
Genomics, Bioinformatics, Biomedicine, Psychiatric medicine |
| Director | Steven Hyman |
| Address | The Ted and Vada Stanley Building, 75 Ames Street, Cambridge, MA 02142 |
| Location | Cambridge, MA |
| Affiliations |
Massachusetts Institute of Technology Harvard University Boston Children's Hospital Brigham and Women's Hospital Massachusetts General Hospital McLean Hospital |
The Stanley Center for Psychiatric Research at Broad Institute of MIT and Harvard is a multi-disciplinary biomedical research program located in Cambridge, Massachusetts that studies the biological basis of psychiatric disease.
The center was founded in 2007 with funding from philanthropists Ted and Vada Stanley.
The Stanley Center for Psychiatric Research at Broad Institute was launched in 2007 with Edward Scolnick, M.D., former head of research and development at Merck Research Laboratories, as its founding director.
Within a year of its inception, researchers at the Center and their international collaborators published a paper on their analysis of a collection of more than 7,000 genetic samples for schizophrenia. The center later launched efforts to collect and sequence genetic samples for such conditions as bipolar disorder, autism spectrum disorders (ASDs) and attention deficit hyperactivity disorder (ADHD), in addition to schizophrenia.
In early 2012, Scolnick stepped down as director and became the Stanley Center’s chief scientist. Steven Hyman, M.D., former director of the National Institute of Mental Health and former provost of Harvard University, was named director of the center.
In July 2014, the Broad Institute announced that Ted Stanley had committed an additional $650 million to the center. The commitment – the largest ever made for psychiatric research—was aimed at “enhancing scientific research on psychiatric disorders with the hopes of leading to a breakthrough in new treatments.”
The announcement coincided with the publication of a paper by Stanley Center researchers and collaborators, as part of the Psychiatric Genomics Consortium, that identified over 100 regions in the human genome associated with schizophrenia through the genetic analysis of 110,000 cases and controls.
The Center consists of more than 150 scientists from the Broad Institute and the Broad’s partner institutions (MIT, Harvard, and Harvard-affiliated hospitals). These include:
...
Wikipedia